Treating cancer with vaccines has been a challenging field of investigation since the 1950s.
Over the years, the lack of effective active immunotherapies has led to the development of …

Therapeutic vaccines represent a viable option for active immunotherapy of cancers that aim
to treat late stage disease by using a patient's own immune system. The promising results …

Cell-based cancer vaccines are a highly attractive alternative to standard cancer therapies.
They theoretically have the capability of inciting a multitargeted therapeutic response that …

Cancer vaccines are solely meant to amplify the pool of type 1 cytokine oriented CD4+ and
CD8+ T cells that recognize tumor antigen and ultimately foster control and destruction of a …

Background: Cancer vaccines are a unique approach to cancer therapy. They exert an
antitumor effect by engaging the host immune response, and have great potential for …

Active, specific immunotherapy for cancer holds the potential of providing an approach for
treating cancers, which have not been controlled by conventional therapy, with very little or …

There are strong biologic and preclinical rationales for the development of therapeutic
cancer vaccines; however, the clinical translation of this treatment strategy has been …

The advent of cancer immunotherapy has revolutionized the field of cancer treatment and
offers cancer patients new hope. Although this therapy has proved highly successful for …

Until now, three types of well‐recognized cancer treatments have been developed, ie,
surgery, chemotherapy, and radiotherapy; these either remove or directly attack the cancer …

Cancer vaccines have been shown clinically to drive tumor-reactive cell activation,
proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer …